Lewis antigen mediated adhesion of freshly removed human bladder tumors to E-selectin

Journal of Urology

Volumn 161, Issue 4, 1999, Pages 1316-1323

  Skorstengaard, Karna ^a   Vestergaard, Else Marie ^a   Langkilde, Niels C ^a   Christensen, Lise Lotte ^a   Wolf, Hans ^a   Ørntoft, Torben F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bladder cancer; Carbohydrate ligands; Cell adhesion; E selectin; Lewis blood groups

Indexed keywords

EDETIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; SELECTIN;

ADHESION; ARTICLE; BLADDER CANCER; BLADDER TUMOR; BLOOD GROUP LEWIS SYSTEM; CARBOHYDRATE ANALYSIS; CELL ADHESION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0032860994     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61677-X     Document Type: Article

References (30)

1. Wolf, H., Kakizoe, T., Smith, P. H., Brosman, S. A., Okajima, E., Rubben, H. and Utz, D. C.: Bladder tumors. Treated natural history. In: Progress in Clinical and Biological Research. Edited by L. Denis, T. Nijima, G. Prout and F. Schröder. New York: Allan R. Liss, pp. 53-70, 1986.
2. Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu K., Preisinger, A. C. and Vogelstein, B.: Clonal origin bladder cancer. N. Engl. J. Med., 326: 737, 1992.
3. Hakomori, S.: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56: 5309, 1996.
4. Takada, A., Ohmori, K., Yoneda, T., Tsuyuoka, K., Hasegawa, A., Kiso, M. and Kannagi, R.: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res., 53: 354, 1993.
5. Varki, A.: Selectin ligands. Proc. Natl. Acad. Sci. USA, 91: 7390, 1994.
6. Li, F., Erickson, H. P., James, J. A., Moore, K. L., Cummings, R. D. and McEver, R. P.: Visualization of P-selection glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J. Biol. Chem., 271: 6348, 1996.
7. Graves, B. J., Crowther, R. L., Chandran, C., Rumberger, J. M., Li, S., Huang, K. S., Presky, D. H., Familletti, P. C., Wohtzky, B. A. and Burns, D. K.: Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature, 367: 532, 1994.
8. Kogan, T. P., Revelle, B. M., Tapp, S., Scott, D. and Beck, P. J.: A single amino acid residue can determine the ligand specificity of E-selectin. J. Biol. Chem., 270: 14047, 1995.
9. Lasky, L. A.: Selectin-carbohydrate interactions and the initiation of the inflammatory response. Ann. Rev. Biochem., 64: 113, 1995.
10. Borges, E., Pendl, G., Eytner, R., Steegmaier, M., Zöllner, O. and Vestweber D.: The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated. J. Biol. Chem., 272: 28786, 1997.
11. Sawada, R., Tsuboi, S. and Fukuda, M.: Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem., 269: 1425, 1994.
12. Ørntoft, T. F., Vestergaard, E. M., Holmes, E., Jakobsen, J. S., Grunnet, N., Mortensen, M., Johnson, P., Bross, P., Gregersen, N., Skorstengaard, K., Jensen, U. B., Bolund, L. and Wolf, H.: Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotypmg, and circulating tumor marker sialyl-Lewis a levels. J. Biol. Chem., 271: 32260, 1996.
13. Elmgren, A., Rydberg, L. and Larson, G.: Genotypic heterogene-ity among Lewis negative individuals. Biochem. Biophys. Res. Commun., 196: 515, 1993.
14. Henry, S., Mollicone, R., Lowe, J. B., Samuelsson, B. and Larson, G.: A second nonsecretor allele of the blood group alpha(1,2)fucosyl-transferase gene (FUT2). Vox Sang., 70: 21, 1996.
15. Kelly, R. J., Rouquier, S., Giorgi, D., Lennon, G. G. and Lowe, J. B.: Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor pheno-type. J. Biol. Chem., 270: 4640, 1995.
16. Meldgaard, P., Holmes, E., Bennett, E. P., Clausen, H., Zeuthen, J. and Ørntoft, T. F.: ABO related glycosylation phenotypes and genotypes in urothelial cell lines of low and high grade malignancy. Cancer Res., 54: 2440, 1994.
17. Ørntoft, T. F., Clausen, H., Johnson, P., Holmes, E., Watkins, W. M. and Hakomori, S.: Lewis transferase and antigens in Le(a-b-) individuals: tissue dependent variable expression of the Lewis gene-encoded a-4-L-fucosyltransferase. Blood, 77: 1389, 1991.
18. Mannori, G., Crottet, P., Cecconi, O., Hanasaki, K., Aruffo, A., Nelson, R. M., Varki, A. and Bevilacqua, M. P.: Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res., 55: 4425, 1995.
19. Handa, K., White, T., Hakomori, S. I. and Hirohashi, S.: A new procedure for establishing functional monoclonal antibodies capable of inhibiting E- or P-selectin-dependent cell adhesion. Glycoconj. J., 14: 39, 1997.
20. Todderud, G., Nair, X., Lee, D., Alford, J., Davern, L., Stanley, P., Bachand, C., Lapointe, P., Marinier, A., Martel, A., Menard, M., Wright, J. J., Bajorath, J., Hollenbaugh, D., Aruffo, A. and Tramposch, K. M.: BMS-190394, a selectin inhibitor prevents rat cutaneous inflammatory reactions. J. Pharmacol. Exp. Ther., 282: 1298, 1997.
21. Schmid, R. A., Yamashita, M., Boasquevisque, C. H., Ando, K., Fujino, S., Phillips, L., Cooper, J. D. and Patterson, G. A.: Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts. J. Heart Lung Transplant, 16: 1054, 1997.
22. Larkin, M., Ahern, T. J., Stoll, M. S., Shaffer, M., Sako, D., O'Brien, J., Yuen, C. T., Lawson, A. M., Childs, R. A. and Barone, K. M.: Spectrum of sialylated and nonsialylated fucooligosaccharides bound by the endothelial-leukocyte adhesion molecule E-selectin. Dependence of the carbohydrate binding activity on E-selectin density. J. Biol. Chem., 267: 13661, 1992.
23. Tyrrell, D., James, P., Rao, N., Foxall, C., Abbas, S., Dasgupta, F., Nashed, M., Hasegawa, A., Kiso, M., Asa, D., Kidd, J. and Brandley, B. K.: Structural requirements for the carbohydrate ligand of E-selectin. Proc. Natl. Acad. Sci. USA, 88: 10372, 1991.
24. Crottet, P., Kim, Y. J. and Varki, A.: Subsets of sialylated, sulfated mucins of diverse origins are recognized by L-selectin. Lack of evidence for unique oligosaccharide sequences mediating binding. Glycobiology, 6: 191, 1996.
25. Yeh, J. and Cummings, R. D.: Differential recognition of glycoprotein acceptors by terminal glycosyltransferases. Glycobiology, 7: 241, 1997.
26. Ørntoft, T. F., Meldgaard, P., Pedersen, B. and Wolf, H.: The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res., 56: 1031, 1996.
27. Handa, K., Stroud, M. R. and Hakomori, S.: Sialosyl-fucosyl Poly-LacNAc without the sialosyl-Lex epitope as the physiological myeloid cell ligand in E-selectin-dependet adhesion: studies under static and dynamic flow conditions. Biochemistry, 36: 12412, 1997.
28. Vestergaard, E. M., Wolf, H. and Ørntoft, T. F.: Increased concentration of genotype-interpreted Ca 19-9 in the urine of bladder cancer patients mark diffuse atypia of the urothelium. Clin. Chem. 1997.
29. Langkilde, N. C., Wolf, H. and Ørntoft, T. F.: Lewis antigen expression in benign and malignant tissues from RBC Le(a-b-) cancer patients. Br. J. Haematol., 79: 493, 1991.
30. Sawada, T., Ho, J. J., Chung, Y. S., Sowa, M. and Kim, Y. S.: E-selectin binding by pancreatic tumor cells is inhibited by cancer sera. Int. J. Cancer, 57: 901, 1994.